Magyar Dermatológiai Társulat MDT őszi rezidens továbbképzés 2018: Dermatoszkópos alapismeretek (Bp., 2018.09.28.) Rendezvény vége: 2018.09.28. Helyszín: 1123 Budapest, Nagyenyed u. 8-14. földszint, Janssen Akadémia (Krisztina Palota) A rendezvény Web oldala: http://derma.hu/kongresszus.aspx?web_id=&cid=16736&p=0 A 2018. évi őszi MDT rezidens továbbképzés témája a "Dermatoszkópos alapismeretek".
Kapcsolódó dokumentumok (1)
Magyar Plasztikai Helyreállító és Esztétikai Sebész Társaság ASPS/ IQUAM Transatlantic Innovations Rendezvény vége: 2009.04.07. Helyszín: France, 75007 Paris, 28 Bis Rue St Dominique, Maison de la Chimie A rendezvény Web oldala: http://www.transatlantic-innovations.org/index.html The scientific program of Transatlantic Innovations has a forward-looking focus on the latest research and breakthrough technology in reconstructive and aesthetic plastic surgery of the face, breast and body. The program will examine the evidence and applications of new technologies and conclude with an IQUAM Consensus Conference chaired by Dr. Connie Neuhann-Lorenz, the results of which will be published in Plastic and Reconstructive Surgery®, and presented to regulatory agencies on both sides of the Atlantic.
www.transatlantic-innovations.org/index.html
Magyar Diabetes Társaság Prediabetes and the Metabolic syndrome Rendezvény vége: 2009.04.04. Helyszín: France, 06302 Nice Cedex 4, 1 esplanade Kennedy- BP4083, Nice-Acropolis A rendezvény Web oldala: http://www2.kenes.com/Prediabetes/pages/home.aspx The Nice 2009 congress will honor two great physicians, both from the USA, who have contributed immensely to research and care of patients with diabetes and CVD. Prof. Jesse Roth - who has introduced the direct study of cell surface receptors and their vital role in transforming hormonal signals to intracellular events. Jesse was a mentor to a great generation of leading diabetes investigators worldwide. Prof. Scott Grundy - a great investigator of the metabolic basis for CVD risk, and a world leader in defining and putting the metabolic syndrome at the center of CVD and diabetes risk.
Homepage >>
